Beginner-friendly– category –
-
Beginner-friendly
From Beginner to Expert | ADC: From Basics to the Frontline – A Deep Dive into the Global ADC Land Grab and Beyond Part 6 – Designing Oncology Portfolios Beyond ADCs: Positioning Bispecifics, Cell Therapies, and Radiopharmaceuticals
In Part 1 of this series, we explored why the ADC land grab is happening now and how ADCs fit into the broader oncology landscape.In Part 2, we review In Part 1 of this series, we explored why the ADC land grab is happening now and how A... -
Beginner-friendly
From Beginner to Expert | ADC: From Basics to the Frontline – A Deep Dive into the Global ADC Land Grab and Beyond Part 5 – The Rise of China and Asian ADC Players: How the Global Map Is Being Redrawn and Where Japan Can Stand
In Part 1 of this series, we explored why the ADC land grab is happening now and how ADCs fit into the broader oncology landscape.In Part 2, we examin In Part 1 of this series, we explored why the ADC land grab is happening now and how A... -
Beginner-friendly
From Beginner to Expert | ADC: From Basics to the Frontline – A Deep Dive into the Global ADC Land Grab and Beyond Part 4 – How to Read ADC Deals: M&A, Licensing, Co-development, and CDMO Agreements
In Part 1 of this series, we looked at why the ADC land grab is happening now and how ADCs fit into the broader oncology landscape.In Part 2, we exami In Part 1 of this series, we looked at why the ADC land grab is happening now and how ... -
Beginner-friendly
From Beginner to Expert | ADC: From Basics to the Frontline – A Deep Dive into the Global ADC Land Grab and Beyond Part 3 – Patent Cliffs and ADCs: Why Big Pharma Wants ADCs as Growth Engines for the Next Decade
In Part 1 of this series, we explored why the ADC land grab is happening now and how ADCs fit within the broader landscape of cancer therapies, highli In Part 1 of this series, we explored why the ADC land grab is happening now and how A... -
Beginner-friendly
From Beginner to Expert | ADC: From Basics to the Frontline – A Deep Dive into the Global ADC Land Grab and Beyond Part 2 – ADC Structure and Generational Shift: What “Second- and Third-generation” ADCs Really Mean After Enhertu
In Part 1 of this series, we asked why the ADC land grab is happening now, and we positioned ADCs within the broader landscape of cancer therapies, di In Part 1 of this series, we asked why the ADC land grab is happening now, and we posi... -
Beginner-friendly
From Beginner to Expert | ADC: From Basics to the Frontline – A Deep Dive into the Global ADC Land Grab and Beyond Part 1 – Why is There an ADC Land Grab Now? Introducing ADC’s Place in Cancer Therapy
Over the past few years, headlines about Antibody-Drug Conjugates (ADCs) have become hard to miss in oncology and biopharma news. Over the past few years, headlines about Antibody-Drug Conjugates (ADCs) have become hard to miss in oncolo... -
Beginner-friendly
Cancer Treatment Introductory–to–Basic Series – Overview
How to Read This 8-Part Series: Seeing the Bigger Picture of Cancer Care The “Cancer Treatment Introductory–to–Basic Series” consists of eight main articles that walk through the big picture of cancer care: overall structur The “Cancer T... -
Beginner-friendly
Cancer Treatment Introductory–to–Basic Series – Part 8 (Final)
Life After Treatment and Survivorship: Shaping How You Live With and Beyond Cancer From Part 1 through Part 7 of this series, we have walked through the basics of cancer treatment: overall structure, differences in “curability” among Fro... -
Beginner-friendly
Cancer Treatment Introductory–to–Basic Series – Part 7
Standard Treatment, Clinical Trials, and Second Opinions: Making Informed Choices In earlier parts of this series, we looked at the overall framework of cancer treatment, differences in “curability” among cancer types, and how to th In e... -
Beginner-friendly
Cancer Treatment Introductory–to–Basic Series – Part 5
Cancer-Specific “Curability”: Why Some Cancers Are Harder to Treat In the previous parts of this series, we looked at the overall framework of cancer treatment and introduced the main tools – surgery, drug therapy, radiotherapy, and part... -
Beginner-friendly
Cancer Treatment Introductory–to–Basic Series – Part 6
Living with Recurrence and Metastasis: Cancer as a Long-Term Journey In Part 5, we explored why some cancers are considered “more curable” or “harder to cure,” focusing on the roles of stage, biology, and overall health. In Part 5, we ex... -
Beginner-friendly
Cancer Treatment Introductory–to–Basic Series – Part 4
Basics of Particle Therapy (Proton and Heavy-Ion): How It Differs from X-ray Radiotherapy In Part 3, we explored the basics of X-ray–based radiotherapy, including external beam radiation, brachytherapy, and high-precision techniques such... -
Beginner-friendly
Cancer Treatment: Introductory–to–Basic Series – Part 3
Basics of Radiotherapy: How It Works, Types, and Roles in Cancer Care In Part 1, we drew an overall map of cancer treatment and looked at why some cancers are easier or harder to cure. In Part 1, we drew an overall map of cancer treatmen... -
Beginner-friendly
Cancer Treatment: Introductory–to–Basic Series – Part 2
How Surgery, Drug Therapy, and Immunotherapy Work Together – And Why Cancer Sometimes Comes Back Lead What you will learn How Surgery, Drug Therapy, and Immunotherapy Work Together – And Why Cancer Sometimes Comes BackChapter 1 Goals and... -
Beginner-friendly
Cancer Treatment: Introductory–to–Basic Series – Part 1
Understanding the Overall Picture of Cancer Treatment and Why Some Cancers Are “Easier” or “Harder” to Cure “Can cancer really be cured?” “If it comes back, does that mean it is over?” These are among the most common and most painful que... -
Beginner-friendly
Summer Beginner Series Grand Summary Part 2|The Rise of Bispecific Antibodies and the Future of Next-Generation Modalities
This article is the second half of the Morningglorysciences Summer Beginner Series Grand Summary. This article is the second half of the Morningglorysciences Summer Beginner Series Grand Summary. In Part 1, we reviewed anti-obesity drugs... -
Beginner-friendly
Summer Beginner Series Grand Summary Part 1|Anti-Obesity Drugs, ADCs, and In vivo CAR-T — From Beginner to Intermediate Insights
This article is the first half of the Morningglorysciences Summer Beginner Series Grand Summary. This article is the first half of the Morningglorysciences Summer Beginner Series Grand Summary. We revisit three major therapeutic modaliti... -
Beginner-friendly
Summer Special Beginner Series Summary|In vivo CAR-T: Evolution and Future of Cellular Immunotherapy
This article is the comprehensive summary of our Morningglorysciences Summer Beginner Series on “In vivo CAR-T.” Previous articles covered the basics, This article is the comprehensive summary of our Morningglorysciences Summer Beginner ... -
Beginner-friendly
Summer Special Beginner Series Summary|Antibody-Drug Conjugates (ADC): Evolution and Future Horizons
This article is the comprehensive summary of our Morningglorysciences Summer Beginner Series on Antibody-Drug Conjugates (ADCs). This article is the comprehensive summary of our Morningglorysciences Summer Beginner Series on Antibody-Dru... -
Beginner-friendly
Summer Special Beginner Series Summary|Anti-Obesity Drugs: From GLP-1 to Next-Generation Therapies
This article is a comprehensive summary of our Morningglorysciences Summer Beginner Series on anti-obesity drugs. This article is a comprehensive summary of our Morningglorysciences Summer Beginner Series on anti-obesity drugs. Throughou...